Skip to main content

Table 2 Variation in prescribing rates by primary care trust (PCT)

From: Exploring the equity of GP practice prescribing rates for selected coronary heart disease drugs: a multiple regression analysis with proxies of healthcare need

Drug group   PCT1 PCT2 PCT3 PCT4
Statins Min 11.05 9.56 6.86 6.44
  Max 47.23 32.12 46.60 45.76
  Median 22.88 19.65 18.08 17.36
  IQR 8.20 11.20 8.40 7.24
Aspirin Min 14.62 15.34 4.94 9.6
  Max 44.97 46.40 46.63 45.65
  Median 29.27 27.35 25.33 30.87
  IQR 7.40 16.5 7.60 18.85
Beta-blockers Min 5.04 6.38 3.94 3.43
  Max 23.92 29.04 23.91 26.19
  Median 12.84 12.38 12.32 12.64
  IQR 4.61 7.70 7.41 10.11
ACE inhibitors Min 15.47 9.85 4.20 4.69
  Max 48.40 39.25 32.97 35.69
  Median 26.43 19.76 16.59 19.19
  IQR 8.82 11.17 9.37 11.29
Bendrofluazide Min 4.19 1.63 1.63 0.60
  Max 35.61 29.55 32.90 22.91
  Median 14.42 10.85 11.04 9.01
  IQR 6.98 8.15 12.70 7.28
All study CHD drugs Min 71.70 57.28 25.89 24.76
  Max 156.82 154.21 136.64 150.68
  Median 105.37 92.78 90.33 83.65
  IQR 28.25 57.07 32.08 51.18
\